Skip to search formSkip to main contentSkip to account menu

MC710

Known as: MC 710, MC-710 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Factor VIIafactor X

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Clinical pharmacological study of a plasma‐derived factor VIIa and factor X mixture (MC710) in haemophilia patients with inhibitors – Phase I trial
Summary.  MC710, a combined product of plasma‐derived activated factor VII (FVIIa) and factor X (FX) at a protein weight ratio of… 
2012
2012
Prospective Efficacy and Safety of a Novel Bypassing Agent, FVIIa/FX Mixture (MC710) for Hemophilia Patients with Inhibitors
Hemophilia A and B are hereditary bleeding disorders caused by a deficiency of coagulation factors VIII (FVIII) and IX (FIX… 
2012
2012
Pharmacokinetics, distribution, and excretion of 125I-labeled human plasma-derived-FVIIa and -FX with MC710 (FVIIa/FX mixture) in rats.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)